{"id":211044,"name":"NERVGEN PHARMA CORP.","slug":"nervgen-pharma-corp","state":null,"country":"Canada","description":"Medical, pharma","totalSpending":420000,"filings":13,"yearlySpending":[{"year":2021,"income":100000},{"year":2022,"income":170000},{"year":2023,"income":70000},{"year":2025,"income":80000}],"issues":["BUD","DEF","HCR","MED","VET"],"firms":["CORNERSTONE GOVERNMENT AFFAIRS, INC."],"lobbyists":["SUSAN SWEAT","JOHN LEGGIERI","WILLIAM SMITH","ANTHONY LAZARSKI","MICHAEL DAVIS","JONATHAN MILLER","ASHLEY PALMER","CHRISTOPHER HODGSON"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Defense, Dept of (DOD)"],"sampleDescriptions":["Advocacy for legislation and funding related to biomedical research and conditions effecting the central nervous system.","Advocacy for legislation and funding related to biomedical research and conditions effecting the central nervous system.","Advocacy for legislation and funding related to biomedical research and conditions effecting the central nervous system.","Issues related to appropriations.","Issues related to defense."],"years":[2021,2022,2023,2025]}